Paper786295
Significance of persisting serologic abnormalities in SLE.
Lightfoot RW and 1 other. Arthritis Rheum, 1976. Cited by 99 papers, by iCite.
Cite this record
ConductScience Library. Significance of persisting serologic abnormalities in SLE. Papers, record 786295. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/786295
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Antinuclear | Major topic |
| Complement System Proteins | Major topic |
| DNA | Major topic |
| Lupus Erythematosus, Systemic | Major topic |
| Adult | |
| Female | |
| Humans | |
| Immunologic Techniques | |
| Male | |
| Recurrence | |
| Remission, Spontaneous |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 99 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7979578 | Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disorders. | Ann Rheum Dis | 1994 | https://conductscience.org/library/papers/7979578 | PubMed |
| 7006525 | Seronegative chronic polyarthritis: clinical and serological correlates. | Ann Rheum Dis | 1980 | https://conductscience.org/library/papers/7006525 | PubMed |
| 6981385 | Prognostic value of anti-dsDNA in SLE. | Ann Rheum Dis | 1982 | https://conductscience.org/library/papers/6981385 | PubMed |
| 6968757 | Antibody to synthetic poly dAT: correlation with antibody to native DNA and specificity for SLE. | J Clin Pathol | 1980 | https://conductscience.org/library/papers/6968757 | PubMed |
| 6859963 | A new specific assay for the detection of DNA immune complexes: its relevance in SLE. | Ann Rheum Dis | 1983 | https://conductscience.org/library/papers/6859963 | PubMed |
| 6761831 | Circulating DNA-antibodies in systemic lupus erythematosus. | Rheumatol Int | 1982 | https://conductscience.org/library/papers/6761831 | PubMed |
| 6608131 | DNA antibodies and complement in SLE patients. A follow-up study. | Rheumatol Int | 1983 | https://conductscience.org/library/papers/6608131 | PubMed |
| 6333314 | Azathioprine in the treatment of systemic lupus erythematosus. A three-year prospective study. | Clin Rheumatol | 1984 | https://conductscience.org/library/papers/6333314 | PubMed |
| 6156950 | Secondary structure in denatured DNA is responsible for its reaction with antinative DNA antibodies of systemic lupus erythematosus sera. | J Clin Invest | 1980 | https://conductscience.org/library/papers/6156950 | PubMed |
| 6153184 | Reaction of systemic lupus erythematosus antinative DNA antibodies with native DNA fragments from 20 to 1,200 base pairs. | J Clin Invest | 1980 | https://conductscience.org/library/papers/6153184 | PubMed |
| 3877968 | Correlation of disease activity with circulating immune complexes (C1qbA) and complement breakdown products (C3D) in patients with systemic lupus erythematosus. A prospective study. | Rheumatol Int | 1985 | https://conductscience.org/library/papers/3877968 | PubMed |
| 3872638 | Reduced opsonisation of protein A containing Staphylococcus aureus in sera with cryoglobulins from patients with active systemic lupus erythematosus. | Ann Rheum Dis | 1985 | https://conductscience.org/library/papers/3872638 | PubMed |
| 3872637 | Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA). | Ann Rheum Dis | 1985 | https://conductscience.org/library/papers/3872637 | PubMed |
| 3792382 | Pulsed methylprednisolone therapy compared to high dose prednisone in systemic lupus erythematosus nephritis. | Eur J Pediatr | 1986 | https://conductscience.org/library/papers/3792382 | PubMed |
| 3753037 | Antibodies to histones and disease activity in systemic lupus erythematosus: a comparative study with an enzyme-linked immunosorbent assay and immunoblotting. | Arch Dermatol Res | 1986 | https://conductscience.org/library/papers/3753037 | PubMed |
| 3581695 | Systemic lupus erythematosus. Follow-up study of 148 patients. II: Predictive factors of importance for course and outcome. | Clin Rheumatol | 1987 | https://conductscience.org/library/papers/3581695 | PubMed |
| 3492026 | Complement (C3) metabolism in systemic lupus erythematosus in relation to the disease course. | Rheumatol Int | 1986 | https://conductscience.org/library/papers/3492026 | PubMed |
| 3488149 | T cell function in systemic lupus erythematosus: normal production of and responsiveness to interleukin 2. | Clin Exp Immunol | 1986 | https://conductscience.org/library/papers/3488149 | PubMed |
| 3487292 | Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. | Ann Rheum Dis | 1986 | https://conductscience.org/library/papers/3487292 | PubMed |
| 3319358 | Attempts towards a serological diagnosis of ankylosing spondylitis. | Clin Rheumatol | 1987 | https://conductscience.org/library/papers/3319358 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/786295
GET https://conductscience.org/api/papers/v1/786295/cited_by?page=2